HSBC Holdings’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,137,094
| Closed | -$203M | – | 2959 |
|
|
2020
Q1 | $203M | Buy |
1,137,094
+150,087
| +15% | +$28.3M | 0.47% | 32 |
|
|
2019
Q4 | $188M | Buy |
987,007
+418,682
| +74% | +$75.5M | 0.33% | 46 |
|
|
2019
Q3 | $95.6M | Buy |
568,325
+544,950
| +2,331% | +$88.8M | 0.18% | 105 |
|
|
2019
Q2 | $3.91M | Sell |
23,375
-131,856
| -85% | -$18.3M | 0.01% | 1242 |
|
|
2019
Q1 | $22.7M | Buy |
155,231
+33,862
| +28% | +$4.91M | 0.04% | 463 |
|
|
2018
Q4 | $16.2M | Buy |
121,369
+490
| +0.4% | +$80.3K | 0.03% | 586 |
|
|
2018
Q3 | $23M | Sell |
120,879
-121,260
| -50% | -$22.3M | 0.04% | 498 |
|
|
2018
Q2 | $40.4M | Buy |
242,139
+23,775
| +11% | +$3.82M | 0.07% | 268 |
|
|
2018
Q1 | $36.7M | Sell |
218,364
-336,243
| -61% | -$56.4M | 0.05% | 337 |
|
|
2017
Q4 | $90.7M | Sell |
554,607
-29,648
| -5% | -$5.32M | 0.13% | 140 |
|
|
2017
Q3 | $120M | Buy |
584,255
+553,037
| +1,772% | +$129M | 0.19% | 95 |
|
|
2017
Q2 | $7.59M | Sell |
31,218
-132,612
| -81% | -$31.2M | 0.01% | 853 |
|
|
2017
Q1 | $39.1M | Buy |
163,830
+147,139
| +882% | +$34.3M | 0.08% | 253 |
|
|
2016
Q4 | $3.5M | Sell |
16,691
-14,614
| -47% | -$3.03M | 0.01% | 1050 |
|
|
2016
Q3 | $7.21M | Buy |
31,305
+12,625
| +68% | +$3.09M | 0.02% | 785 |
|
|
2016
Q2 | $4.32M | Sell |
18,680
-66,185
| -78% | -$15.3M | 0.01% | 952 |
|
|
2016
Q1 | $22.7M | Buy |
84,865
+81,830
| +2,696% | +$23.4M | 0.06% | 358 |
|
|
2015
Q4 | $950K | Sell |
3,035
-30,305
| -91% | -$9.02M | ﹤0.01% | 1482 |
|
|
2015
Q3 | $9.06M | Sell |
33,340
-499,886
| -94% | -$154M | 0.02% | 631 |
|
|
2015
Q2 | $162M | Buy |
533,226
+233,481
| +78% | +$69.6M | 0.33% | 60 |
|
|
2015
Q1 | $89.2M | Buy |
299,745
+138,478
| +86% | +$39.5M | 0.17% | 118 |
|
|
2014
Q4 | $41.5M | Sell |
161,267
-60,232
| -27% | -$15.1M | 0.09% | 244 |
|
|
2014
Q3 | $53.4M | Buy |
221,499
+169,386
| +325% | +$37.9M | 0.11% | 183 |
|
|
2014
Q2 | $11.6M | Sell |
52,113
-4,281
| -8% | -$886K | 0.03% | 565 |
|
|
2014
Q1 | $11.6M | Buy |
56,394
+16,246
| +40% | +$3.22M | 0.03% | 523 |
|
|
2013
Q4 | $6.75M | Sell |
40,148
-67,868
| -63% | -$10.6M | 0.02% | 767 |
|
|
2013
Q3 | $15.6M | Buy |
108,016
+7,849
| +8% | +$1.05M | 0.04% | 456 |
|
|
2013
Q2 | $12.6M | Buy |
+100,167
| New | +$11.3M | 0.04% | 449 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
HSBC Holdings's AGN Position: Q2 2020 in Review
HSBC Holdings sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,137,094 shares — an estimated $203M sold.
HSBC Holdings first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $203M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- HSBC Holdings reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- HSBC Holdings sold 1,137,094 Allergan plc shares in Q2 2020, an estimated $203M.
- HSBC Holdings first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- HSBC Holdings's Allergan plc position peaked at $203M in Q1 2020.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on HSBC Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.